Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 6Diarrhea 4Rectal Neoplasms 2Ovarian Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Short Bowel Syndrome 1Neoplasms 1Melanoma 1Lung Neoplasms 1Low Anterior Resection Syndrome 1Exanthema 1Esophageal Squamous Cell Carcinoma 1Endometrial Neoplasms 1Colorectal Cancer Metastatic 1Colitis, Ulcerative 1Colitis 1Chemotherapy-related Diarrhea 1

Interventions

Nivolumab 2Infliximab 2Educational Status 2Colonoscopy 2vedolizumab 1pembrolizumab 1golimumab 1Vitamin E 1Sutures 1Surgical Instruments 1Standard of Care 1Specimen Handling 1Ringer's Lactate 1Proctocolectomy, Restorative 1Proctectomy 1Practice Guidelines as Topic 1Pneumococcal Vaccines 1Papillomavirus Vaccines 1Narrow Band Imaging 1Methods 1Lysine Acetyltransferase 5 1Loperamide 1Laparoscopy 1Iron-Dextran Complex 1Interviews as Topic 1Indigo Carmine 1Hydroxyethyl Starch Derivatives 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Endoscopy 1Eicosapentaenoic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Colitis, Ulcerative × Loperamide × Clear all
NCT02266849 2016-10-11

Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study

Odense University Hospital

Phase 3 Terminated
12 enrolled
Gastrointestinal

Colitis, Ulcerative, Rectal Neoplasms, Short Bowel Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡